CornerCap Investment Counsel »

Relay Therapeutics shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $254k 23k 11.01
2023-09-30 $194k 23k 8.41

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Relay Therapeutics

Vanguard Group
T. Rowe Price Associates
Casdin Capital
Jpmorgan Chase & Co
Bellevue Group
BVF
Arrowpoint Asset Management
Norges Bank Investment Management
Boxer Capital
Jacobs Levy Equity Management
Alphabet
Dimensional Fund Advisors
Nextech Invest
Baker Bros. Advisors
Goldman Sachs Group

View all funds holding Relay Therapeutics